Article Sidebar
Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Disodium Cromoglycate (Lomudal) in Asthma with Emphasis on Lung Function Tests
Abstract
Twenty allergic asthmatics were treated with inhaled disodium cromoglycate (Lomudallt in addition to extant therapy. Improvement was assessed by the patient, clinically by the physician, by analysis of the patients' diary cards and by a battery of pulmonary function tests, after 3 months' treatment. Eighteen patients were improved. At the end of 1 year's treatment, only 1 failed to maintain improvement. No serious side-effects were encountered. Lung function tests demonstrated less hyperinflation in 9 out of 11 patients tested, less airway obstruction in 14 out of 20, no change in a standardized exercise test and an improvement in acid-base balance from compensated respiratory alkalosis to normal. The results in this trial are discussed in relation to others in this literature. The value of DSCG in facilitating reduction of corticosteroid and sympathomimetic therapy for asthma is emphasized. Some practical points in the use of DSCG are listed. Disodium cromoglycate is safe and efficacious in allergic bronchial asthma and is a very useful adjunct in the therapy of this common, potentially serious condition.
